Artificial Intelligence (AI) applications are increasingly used in the surveillance of an outbreak as well as care of patients with SARS-CoV-2 virus and those with COVID-19 disease. Applications of AI in COVID-19 can range from outbreak prediction, detecting and tracking COVID-19 cases to vaccine rollouts for COVID-19. Patient-Centered Outcomes Research Institute (PCORI) commissioned this emerging technology report for a review of AI in clinical care and public health management of COVID-19.
The purpose of the evidence review will be to identify AI applications that aid in diagnosis, therapy, and management of patients either diagnosed with or suspected of having COVID-19; and for optimizing public health measures, such as vaccine strategies, contact tracing, and others. The report will also include a framework to identify ways in which AI could enhance health equity around clinical, public health, and societal aspects during pandemic. Additionally, this framework’s objective would be to place current research in context and to help identify research gaps that future research could address on health equity in COVID-19.
About the Emerging Technologies and Therapeutics Reports
The Emerging Technologies and Therapeutics Reports provide timely summaries of evidence supporting new drugs, devices, and other healthcare technologies that are recently in use or may be available in the near term in the United States. The documents also identify gaps that need to be addressed for the technologies or therapeutics to move forward.
- Other Evidence Products
The state where the project originates, or where the primary institution or organization is located.